September 22, 2023
Closing of Second Tranche of Private Placement Financing, Amendment to Terms of Secured Debt and Director ChangeSeptember 14, 2023
Rapid Dose Provides Update on Private PlacementSign up to get full access to all our latest Press Releases
Sign UpSign up to get full access to all our latest Press Releases
Sign UpRAPID DOSE THERAPEUTICS INC.
Listing/Symbol: CSE: DOSE
Fiscal Year-End: February 28
Auditors: SRCO Professional Corporation
Legal Counsel:
Harris & Harris
c/o Greg Harris
Share Structure
Shares issued & outstanding
Shares outstanding July 31, 2023
Common Shares 103,574,267
Reserved for issuance:
Warrants 8,276,382
Options 5,350,000
Fully diluted _______________
117,200,649
For inquiries
Email: info@rapid-dose.com
Phone: 1 (416)-477-1052